Saudi Arabia’s General Authority for Competition (GAC) issued 21 decisions on economic concentration applications in June. It approved Kingdom Holding Co.’s (KHC) acquisition of a 70% stake in Al Hilal Club Co.
According to Argaam data, KHC signed an agreement with the Public Investment Fund (PIF) in April to buy the stake for SAR 840 million, based on an enterprise value of about SAR 1.4 billion and an equity valuation of SAR 1.2 billion.
GAC also gave the go-ahead for the full acquisition of Dr. Mohammed bin Rashid Al Fakeeh Partners Co. by TASI-listed Dr. Soliman Fakeeh Hospital Co., as well as Jamjoom Pharmaceuticals Factory Co.’s acquisition of a biopharmaceutical manufacturing facility.
Saudi Arabia’s General Authority for Competition (GAC) issued 21 decisions on economic concentration applications in June. It approved Kingdom Holding Co.’s (KHC) acquisition of a 70% stake in Al Hilal Club Co.
According to Argaam data, KHC signed an agreement with the Public Investment Fund (PIF) in April to buy the stake for SAR 840 million, based on an enterprise value of about SAR 1.4 billion and an equity valuation of SAR 1.2 billion.
GAC also gave the go-ahead for the full acquisition of Dr. Mohammed bin Rashid Al Fakeeh Partners Co. by TASI-listed Dr. Soliman Fakeeh Hospital Co., as well as Jamjoom Pharmaceuticals Factory Co.’s acquisition of a biopharmaceutical manufacturing facility.
